# An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

> **NCT06427369** · PHASE1 · WITHDRAWN · sponsor: **Roswell Park Cancer Institute**

## Conditions studied

- Extensive-stage Small-cell Lung Cancer
- Limited-stage Small-cell Lung Cancer
- Lung Non-Small Cell Carcinoma
- Stage IIIA Lung Cancer
- Stage IV Lung Cancer

## Interventions

- **OTHER:** Radioconjugate
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** FDG-Positron Emission Tomography and Computed Tomography Scan
- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT06427369
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-10-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** prioritization
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06427369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06427369, "An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06427369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*